Chicago, Ill.– Press Ganey has named Dr. Avanish Mishra as President of Life Sciences, marking a strategic move to expand the company’s presence and impact across the pharmaceutical and biotechnology sectors. In his new role, Dr. Mishra will report directly to Press Ganey Forsta Chairman and CEO Patrick T. Ryan.
A seasoned executive with over two decades of global experience, Dr. Mishra brings a blend of scientific and commercial leadership from previous roles at Thermo Fisher Scientific, Gilead, and Pfizer. Most recently, he served as General Manager of Real World Data at Thermo Fisher, where he led key growth initiatives, including the company’s global COVID-19 response efforts.
At Press Ganey, Dr. Mishra will lead the company’s efforts to transform how life sciences companies engage with patients and providers throughout the entire product lifecycle—from clinical development through to commercial delivery. His work will focus on leveraging Press Ganey’s strengths in experience analytics, data science, and technology to provide life sciences partners with deeper insights, faster decision-making capabilities, and more personalized engagement strategies.
“Avanish is a proven innovator with the scientific depth and commercial expertise to scale solutions for complex challenges,” said CEO Patrick T. Ryan. “His appointment marks a pivotal step in our strategy to bring more human-centered, insight-driven solutions to the life sciences industry.”
Dr. Mishra’s career spans leadership positions across the U.S., Japan, and Asia-Pacific markets. During his tenure at Pfizer, he helped launch and grow a joint venture that generated more than $400 million in revenue within three years. He holds a Ph.D. in Pharmacy Administration and has authored several influential scientific publications.
His appointment underscores Press Ganey’s commitment to integrating patient and provider experience more deeply into the development and delivery of therapies, aligning with broader industry trends toward personalized care and value-based outcomes.
